BioSpace News Archive

Browse BioSpace’s published news and press releases by year, month, and day.
42 Results
Year
Month
Day
  • Orphazyme A/S in restructuring, a late-stage biopharmaceutical company, announces that an in-court meeting was held where the restructuring proposal as published by the Company through company announcement no. 26/2022 on May 18, 2022, was approved by the Company’s creditors and affirmed by the Danish Maritime and Commercial High Court in accordance with sections 13 d and 13 e of the Danish Insolvency Act.
  • Transcenta Holding Limited announces that Nature Cancer, an international authoritative journal in oncology field, publishes the results of preclinical studies of Transcenta’s first-in-class Gremlin1 targeting antibody in the treatment of castration resistant prostate cancer.